Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial
Publication
, Conference
Rao, P; Alexander, JH; Wojdyla, D; Atar, D; Hylek, EM; Hanna, M; Parkhomenko, A; Vinereanu, D; Wallentin, L; Lopes, RD; Gersh, BJ; Granger, CB
Published in: EUROPEAN HEART JOURNAL
August 1, 2016
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2016
Volume
37
Start / End Page
233 / 234
Location
Rome, ITALY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, P., Alexander, J. H., Wojdyla, D., Atar, D., Hylek, E. M., Hanna, M., … Granger, C. B. (2016). Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 37, pp. 233–234). Rome, ITALY: OXFORD UNIV PRESS.
Rao, P., J. H. Alexander, D. Wojdyla, D. Atar, E. M. Hylek, M. Hanna, A. Parkhomenko, et al. “Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 37:233–34. OXFORD UNIV PRESS, 2016.
Rao P, Alexander JH, Wojdyla D, Atar D, Hylek EM, Hanna M, et al. Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2016. p. 233–4.
Rao, P., et al. “Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 37, OXFORD UNIV PRESS, 2016, pp. 233–34.
Rao P, Alexander JH, Wojdyla D, Atar D, Hylek EM, Hanna M, Parkhomenko A, Vinereanu D, Wallentin L, Lopes RD, Gersh BJ, Granger CB. Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2016. p. 233–234.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2016
Volume
37
Start / End Page
233 / 234
Location
Rome, ITALY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology